Trademark: 98112146
Word
MODE
Status
Pending
Status Code
730
Status Date
Tuesday, April 2, 2024
Serial Number
98112146
Mark Type
4000
Filing Date
Tuesday, August 1, 2023
Published for Opposition
Tuesday, October 31, 2023

Trademark Owner History
Biohaven Therapeutics Ltd. - Owner At Publication

Classifications
5 Pharmaceutical products, namely, multifunctional molecules that bind to extracellular circulating disease-causing proteins and other biomolecules and target them for lysosomal degradation, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancers, infectious diseases, and neurological disorders
42 Discovery in the nature of pharmaceutical research, development, engineering and testing, namely, for multifunctional molecules that bind to extracellular circulating disease-causing proteins and other biomolecules and target them for lysosomal degradation, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancers, infectious diseases, and neurological disorders

Trademark Events
Apr 3, 2024
Notice Of Approval Of Extension Request E-Mailed
Apr 2, 2024
Sou Extension 1 Granted
Apr 2, 2024
Sou Extension 1 Filed
Apr 2, 2024
Sou Teas Extension Received
Jan 5, 2024
Assigned To Examiner
Dec 26, 2023
Noa E-Mailed - Sou Required From Applicant
Nov 29, 2023
Teas Change Of Correspondence Received
Nov 29, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Nov 29, 2023
Teas Change Of Owner Address Received
Oct 31, 2023
Official Gazette Publication Confirmation E-Mailed
Oct 31, 2023
Published For Opposition
Oct 11, 2023
Notification Of Notice Of Publication E-Mailed
Sep 25, 2023
Approved For Pub - Principal Register
Sep 23, 2023
Assigned To Examiner
Aug 30, 2023
New Application Office Supplied Data Entered
Aug 4, 2023
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24